PortfoliosStock ScreensStocksStockXcel

Bafna Pharmaceuticals Limited

BAFNAPH | NSE

136.02

INR

-1.00

-0.73%

BAFNAPH | NSE
Loading StockChartView...

About Bafna Pharmaceuticals Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

31/03/2024

As of date

24/04/2026

Close

136.02

Open

134.00

High

138.80

Low

134.00

View Less

BAFNAPH | NSE

Risk
66.0
Sharpe
1.50
Luna's Score
57/100
Recommendation
Hold

Luna says (BAFNAPH | NSE)

What's Working

Low Market Beta (-0.4 to 0.8)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

Strong Sharpe Ratio (> 1.2)

What's not Working

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

54.3%

1 month

66.0%

3 months

59.2%

6 months

53.5%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

674.92

Fwd. PE

-

Price to book

2.34

Debt to equity

0.30

Debt to assets

0.17

Ent. to EBITDA

14.27

Ent. to rev.

1.34

PEG

-

Other Fundamentals

EBITDA

57.11M

MarketCap

3.23B

MarketCap(USD)

33.81M

Div. yield

-

Op. margin

-0.70

Erngs. growth

-73.50

Rev. growth

-20.60

Ret. on equity

9.52

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

21.65

Range1M

39.96

Range3M

53.18

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.12

Price X volume

82.84K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Medico Remedies LimitedMEDICODrug Manufacturers-Specialty & Generic40.863.25B-2.51%45.5315.37%
Medicamen Biotech LimitedMEDICAMEQDrug Manufacturers-Specialty & Generic257.663.18B-0.70%82.7415.37%
Nectar Lifesciences LimitedNECLIFEDrug Manufacturers-Specialty & Generic11.792.67B-2.24%138.0759.44%
Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSDrug Manufacturers-Specialty & Generic88.332.56B-1.72%32.7523.61%
Kilitch Drugs (India) LimitedKILITCHDrug Manufacturers-Specialty & Generic152.142.46B-4.54%42.4417.95%
Lyka Labs LimitedLYKALABSBiotechnology57.582.06B-2.75%813.9486.05%
Brooks Laboratories LimitedBROOKSDrug Manufacturers-Specialty & Generic67.541.80B4.94%n/a8.60%
Alpa Laboratories LimitedALPADrug Manufacturers-Specialty & Generic68.481.45B-1.38%13.543.45%
Krebs Biochemicals & Industries LimitedKREBSBIODrug Manufacturers-Specialty & Generic59.331.27B-0.22%n/a-162.25%
Bal Pharma LimitedBALPHARMADrug Manufacturers-Specialty & Generic76.31.22B-2.30%25.83201.53%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Madhav Copper LimitedMCLCopper591.63B-1.55%82.2232.14%
Cubex Tubings LimitedCUBEXTUBCopper89.311.30B-1.13%35.8521.78%
Touchwood Entertainment LimitedTOUCHWOODAdvertising Agencies75.31839.62M0.39%50.064.88%
Sagardeep Alloys LimitedSAGARDEEPCopper23.58409.35M-2.16%58.6243.14%
Heads UP Ventures LimitedHEADSUPApparel Retail7.29159.72M0.00%n/a0.00%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA14.2724.85Cheaper
Ent. to Revenue1.3411.40Cheaper
PE Ratio674.9251.36Expensive
Price to Book2.346.83Cheaper
Dividend Yield-0.52-
Std. Deviation (3M)59.2442.17Riskier
Debt to Equity0.300.35Par
Debt to Assets0.170.17Par
Market Cap3.23B290.82BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007